CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study. [electronic resource]
Producer: 20050630Description: 693-701 p. digitalISSN:- 0271-9142
- Adjuvants, Immunologic -- administration & dosage
- Adolescent
- Adult
- Antibody Formation
- Double-Blind Method
- Female
- Hepatitis B Surface Antigens -- administration & dosage
- Hepatitis B Vaccines -- administration & dosage
- Humans
- Immunophenotyping
- Male
- Membrane Glycoproteins -- agonists
- Oligodeoxyribonucleotides -- administration & dosage
- Receptors, Cell Surface -- agonists
- T-Lymphocytes -- immunology
- T-Lymphocytes, Cytotoxic -- immunology
- Toll-Like Receptor 9
- Toll-Like Receptors
- Vaccines, Synthetic -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.